SCHEMBL23167300

SCHEMBL23167300

Cc1cc(Br)ccc1-c1cc(Cl)ccc1[N+](=O)[O-]

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 3/20 0.47
▸ TSHR P16473 2/20 0.47
▸ HSD11B1 P28845 1/20 0.43
▸ LMNA P02545 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ PDE7A Q13946 2/20 0.42
▸ PDE7B Q9NP56 2/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ S100A4 P26447 1/20 0.41
▸ TRPV1 Q8NER1 1/20 0.41
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ NPBWR1 P48145 1/20 0.39
▸ MAPT P10636 3/20 0.39
▸ VCAM1 P19320 1/20 0.39
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11516745 0.80 MAPK1 (0.69) MAPK1TSHRLMNAPOLBPDE7A
SCHEMBL31903 0.80 HSD17B10 (0.50) TSHRHSD11B1ALDH1A1S100A4TRPV1
SCHEMBL23167082 0.79 MAPK1 (0.47) MAPK1TSHRHSD11B1LMNAPOLB
SCHEMBL23166960 0.78 MAPK1 (0.53) MAPK1TSHRLMNAPOLBPDE7A
SCHEMBL1459853 0.77 MAPT (0.56) TSHRALDH1A1S100A4TRPV1MAPT
SCHEMBL31005993 0.77 MAPT (0.56) TSHRALDH1A1S100A4TRPV1MAPT
SCHEMBL17727815 0.77 HSD11B1 (0.59) MAPK1TSHRHSD11B1PDE7APDE7B
SCHEMBL26205134 0.77 S100A4 (0.56) MAPK1TSHRALDH1A1S100A4TRPV1
SCHEMBL23167170 0.77 S100A4 (0.44) MAPK1TSHRHSD11B1S100A4TRPV1
SCHEMBL29966820 0.77 S100A4 (0.44) MAPK1TSHRHSD11B1S100A4TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12384760-B2 Substituted carbazole compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2025-08-12 — — US disclosed
CN-114829350-B Substituted carbazole compounds 百时美施贵宝公司 2024-05-28 — — CN disclosed
US-20240076280-A1 SUBSTITUTED CARBAZOLE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2024-03-07 — — US disclosed
EP-4038059-B1 SUBSTITUTED CARBAZOLE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2023-09-20 — — EP disclosed
EP-4038059-B1 SUBSTITUTED CARBAZOLE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2023-09-20 — — EP disclosed
EP-4038059-A1 SUBSTITUTED CARBAZOLE COMPOUNDS Bristol-Myers Squibb Company (US) 2022-08-10 — — EP disclosed
CN-114829350-A Substituted carbazole compounds 百时美施贵宝公司 2022-07-29 — — CN disclosed
WO-2021067657-A1 SUBSTITUTED CARBAZOLE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2021-04-08 — — WO disclosed
WO-2021067657-A1 SUBSTITUTED CARBAZOLE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2021-04-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240076280-A1 SUBSTITUTED CARBAZOLE COMPOUNDS TLR7, TLR3, TLR1 MAPK1 519/4885TSHR 530/4885HSD11B1 3568/4885
US-12384760-B2 Substituted carbazole compounds TLR7, TLR3, TLR1 MAPK1 519/4885TSHR 530/4885HSD11B1 3568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback